Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-Early Clinical Studies Group (ECSG)
2008 ◽
Vol 63
(5)
◽
pp. 903-910
◽
2010 ◽
Vol 16
(9)
◽
pp. 2656-2665
◽
2006 ◽
Vol 12
(12)
◽
pp. 3774-3781
◽
2014 ◽
Vol 74
(6)
◽
pp. 1191-1198
◽
2002 ◽
Vol 128
(6)
◽
pp. 313-318
◽
2009 ◽
Vol 19
(4)
◽
pp. 261-266
◽